This Workday Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Workday
Pulse Biosciences, Inc.
Dave, Inc. Class A
Bain Capital Specialty Finance
Crescent Capital BDC, Inc.
Workday WDAY | 0.00 | |
Pulse Biosciences, Inc. PLSE | 0.00 | |
Dave, Inc. Class A DAVE | 0.00 | |
Bain Capital Specialty Finance BCSF | 0.00 | |
Crescent Capital BDC, Inc. CCAP | 0.00 |
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Keefe, Bruyette & Woods analyst Paul Johnson downgraded Crescent Capital BDC Inc (NASDAQ:CCAP) from Outperform to Market Perform and cut the price target from $13 to $12. Crescent Capital closed at $11.15 on Friday. See how other analysts view this stock.
- BTIG analyst Allan Verkhovski downgraded Workday Inc (NASDAQ:WDAY) from Buy to Neutral. Workday shares closed at $198.68 on Friday. See how other analysts view this stock.
- Seaport Global analyst Daniel Mckenzie downgraded JetBlue Airways Corp (NASDAQ:JBLU) from Buy to Neutral. JetBlue closed at $5.65 on Friday. See how other analysts view this stock.
- JP Morgan analyst Jeffrey Zekauskas downgraded Amcor PLC (NYSE:AMCR) from Overweight to Neutral and raised the price target from $44 to $47. Amcor shares closed at $46.03 on Friday. See how other analysts view this stock.
- Maxim Group analyst Anthony Vendetti downgraded cbdMD Inc (AMEX:YCBD) from Buy to Hold. cbdMD closed at $0.50 on Friday. See how other analysts view this stock.
Considering buying WDAY stock? Here’s what analysts think:
Photo via Shutterstock